US 12,153,015 B2
Gel electrophoresis diagnostic kit and methods of using the same
Mounir A. Koussa, Kitchener (CA); Calvin Domenico, Herndon, VA (US); Ronald L. Green, Bethel, CT (US); Joshua John Forman, Winchester, MA (US); Andrew Ward, Everett, MA (US); and Lisa Caldwell, Westford, MA (US)
Assigned to Vital Biosciences Inc., Kitchener (CA)
Filed by Vital Biosciences Inc., Kitchener (CA)
Filed on May 22, 2023, as Appl. No. 18/321,251.
Application 18/321,251 is a continuation of application No. 17/036,076, filed on Sep. 29, 2020, granted, now 11,692,967.
Application 17/036,076 is a continuation of application No. 16/321,723, granted, now 10,823,699, issued on Nov. 3, 2020, previously published as PCT/US2017/044544, filed on Jul. 28, 2017.
Claims priority of provisional application 62/452,429, filed on Jan. 31, 2017.
Claims priority of provisional application 62/368,635, filed on Jul. 29, 2016.
Prior Publication US 2023/0384262 A1, Nov. 30, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. G01N 27/447 (2006.01); G01N 27/453 (2006.01); G01N 33/561 (2006.01)
CPC G01N 27/453 (2013.01) [G01N 27/44743 (2013.01); G01N 33/561 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A base for reading a biomarker detector cartridge, wherein the biomarker detector cartridge comprises:
(a) a cartridge body;
(b) a fluid collector;
(c) an electrophoretic cell; and
(d) a nanoswitch;
the base comprising:
a biomarker detector cartridge receiver;
electrical contacts proximate to the cartridge receiver configured to communicate with the electrophoretic cell of the biomarker detector cartridge; and
an electrophoretic cell reader proximate to the cartridge receiver.